Isolation and Characterization of Milk Exosomes for Use in Advanced Therapies
Biomolecules · 08.07.2024 · 14 (7) · 810
DOI: 10.3390/biom14070810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 08.07.2024. Verfasst von Ana Medel-Martinez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Sanitarias de Aragón (IIS Aragón), 50009 Zaragoza, Spain. Hauptthemen laut MEDLINE: Exosomes, Milk. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII), ASPANOA and AECC grants, Fondo Europeo de Desarrollo Regional (Feder) “Una manera de hacer Europa”.
Abstract (Originalsprache)
Exosomes are cell-derived extracellular vesicles (EVs) with diameters between 30 and 120 nm. In recent years, several studies have evaluated the therapeutic potential of exosomes derived from different fluids due to their low immunogenicity and high biocompatibility. However, producing exosomes on a large scale is still challenging. One of the fluids from which they could be isolated in large quantities is milk. Moreover, regeneration is a well-known property of milk. The present work seeks to optimize a method for isolating exosomes from bovine and human milk, comparing different storage conditions and different extraction protocols. We found differences in the yield extraction associated with pre-storage milk conditions and observed some differences according to the processing agent. When we removed milk fat globules and added rennet before freezing, we obtained a cleaner final fraction. In summary, we attempted to optimize a rennet-based new milk–exosome isolation method and concluded that pre-treatment, followed by freezing of samples, yielded the best exosome population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigaciones Sanitarias de Aragón (IIS Aragón), 50009 Zaragoza, Spain.
- Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain.
- Instituto de Nanociencia y Materiales de Aragon (INMA), CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, 50018 Zaragoza, Spain.
- Networking Research Center in Biomaterials, Bioengineering and Nanomedicine (CIBERBBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Chemical and Environmental Engineering, University of Zaragoza, Campus Rio Ebro, C/María de Luna, 3, 50018 Zaragoza, Spain.
- Instituto Agroalimentario de Aragón, University of Zaragoza, 50018 Zaragoza, Spain.
ORCID-Profile: Maria Sancho-Albero, Lourdes Sánchez, Víctor Sebastián, María Pardo, Antonio de la Vieja
Förderung
- Instituto de Salud Carlos III (ISCIII)
- ASPANOA and AECC grants
- Fondo Europeo de Desarrollo Regional (Feder) “Una manera de hacer Europa”
- VI National R&D&i Plan 2008–2011
- Spanish Ministerio de Ciencia e Innovacion (MICIN) and Fondo Europeo de Desarrollo Regional (FEDER)
- AECC
Zitieren
APA
Medel-Martinez, A., Redrado-Osta, A., Crespo-Barreda, A., Sancho-Albero, M., Sánchez, L., Sebastián, V., Pardo, M., de la Vieja, A., & Martín-Duque, P. (2024). Isolation and Characterization of Milk Exosomes for Use in Advanced Therapies. Biomolecules, 14(7), 810. https://doi.org/10.3390/biom14070810
Vancouver
Medel-Martinez A, Redrado-Osta A, Crespo-Barreda A, Sancho-Albero M, Sánchez L, Sebastián V, et al. Isolation and Characterization of Milk Exosomes for Use in Advanced Therapies. Biomolecules. 2024;14(7):810. doi:10.3390/biom14070810
BibTeX
@article{MedelMartinez2024,
author = {Medel-Martinez, Ana and Redrado-Osta, Ana and Crespo-Barreda, Alejandra and Sancho-Albero, Maria and Sánchez, Lourdes and Sebastián, Víctor and Pardo, María and de la Vieja, Antonio and Martín-Duque, Pilar},
title = {Isolation and Characterization of Milk Exosomes for Use in Advanced Therapies},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {7},
pages = {810},
doi = {10.3390/biom14070810}
}
EUVIMED